Durvanei Augusto Maria

Title: Durvanei Augusto Maria: Innovator in Pharmaceutical Sciences

Introduction

Durvanei Augusto Maria is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative treatments for neoplastic diseases. With a total of 4 patents to his name, his work has the potential to impact both human and animal health.

Latest Patents

One of his latest patents involves a pharmaceutical composition and its use for the treatment, prophylaxis, or prevention of neoplastic diseases in humans and animals. This invention focuses on pharmaceutical compositions that comprise polyfunctional metal phenolates, which serve as anticancer adjuvants, cytoprotective antimetastatic agents, and antimutagenic agents when used in conjunction with chemotherapy drugs. Another significant patent pertains to methods for preparing penta-1,4-dien-3-ones and substituted cyclohexanones, which exhibit antitumoral and antiparasitic properties. These compounds have shown strong antitumoral activity and promising antiparasitic action, demonstrating low toxicity in laboratory assays and histopathological studies.

Career Highlights

Durvanei has worked with several organizations throughout his career, including Biolabs Sanus Farmaceutica Ltda. and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). His experience in these institutions has allowed him to advance his research and contribute to the development of effective pharmaceutical solutions.

Collaborations

Throughout his career, Durvanei has collaborated with esteemed colleagues such as Ana Marisa Chudzinski-Tavassi and José Agustin Quincoces Suárez. These partnerships have enriched his research and expanded the scope of his innovations.

Conclusion

Durvanei Augusto Maria stands out as a prominent inventor in the pharmaceutical field, with a focus on developing innovative treatments for neoplastic diseases. His contributions have the potential to significantly enhance therapeutic options for patients, showcasing the importance of research and innovation in healthcare.